Effectiveness of renal sympathetic denervation in renal function and blood pressure in CKD and non-CKD patients with controlled uncontrolled hypertension.
作者信息
Kiuchi Márcio Galindo, Chen Shaojie
机构信息
Division of Cardiac Surgery and Artificial Cardiac Stimulation, Department of Medicine, Hospital e Clínica São Gonçalo, São Gonçalo, RJ, Brazil.
Department of Cardiology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
出版信息
Int J Cardiol Heart Vasc. 2016 Sep 7;13:3-5. doi: 10.1016/j.ijcha.2016.09.001. eCollection 2016 Dec.
Abstract
摘要
相似文献
1
Effectiveness of renal sympathetic denervation in renal function and blood pressure in CKD and non-CKD patients with controlled uncontrolled hypertension.
Int J Cardiol Heart Vasc. 2016 Sep 7;13:3-5. doi: 10.1016/j.ijcha.2016.09.001. eCollection 2016 Dec.
2
Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
Hipertens Riesgo Vasc. 2018 Apr-Jun;35(2):54-63. doi: 10.1016/j.hipert.2017.07.002. Epub 2017 Aug 4.
3
Total renal denervation reduces sympathoexcitation to different target organs in a model of chronic kidney disease.
Auton Neurosci. 2017 May;204:81-87. doi: 10.1016/j.autneu.2016.11.006. Epub 2016 Dec 1.
4
Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
Int J Cardiol. 2016 Nov 15;223:494-496. doi: 10.1016/j.ijcard.2016.08.262. Epub 2016 Aug 16.
5
Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
J Interv Card Electrophysiol. 2018 Jan;51(1):51-59. doi: 10.1007/s10840-017-0302-2. Epub 2017 Dec 20.
6
Renal Denervation Improves the Baroreflex and GABA System in Chronic Kidney Disease-induced Hypertension.
Sci Rep. 2016 Dec 5;6:38447. doi: 10.1038/srep38447.
7
Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Curr Hypertens Rep. 2018 Sep 7;20(11):92. doi: 10.1007/s11906-018-0893-8.
8
Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure lowering in chronic kidney disease.
Auton Neurosci. 2017 May;204:88-97. doi: 10.1016/j.autneu.2016.09.018. Epub 2016 Oct 4.
9
Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
Exp Physiol. 2017 Nov 1;102(11):1414-1423. doi: 10.1113/EP086370. Epub 2017 Oct 4.
10
Synergy of pulmonary vein isolation and catheter renal denervation in atrial fibrillation complicated with uncontrolled hypertension: Mapping the renal sympathetic nerve and pulmonary vein (the pulmonary vein isolation plus renal denervation strategy)?
J Cardiovasc Electrophysiol. 2019 May;30(5):658-667. doi: 10.1111/jce.13858. Epub 2019 Feb 2.
引用本文的文献
1
Patient-Specific Factors Predicting Renal Denervation Response in Patients With Hypertension: A Systematic Review and Meta-Analysis.
J Am Heart Assoc. 2024 Jul 16;13(14):e034915. doi: 10.1161/JAHA.124.034915. Epub 2024 Jul 9.
本文引用的文献
1
Proof of concept study: renal sympathetic denervation for treatment of polymorphic premature ventricular complexes.
J Interv Card Electrophysiol. 2016 Nov;47(2):221-229. doi: 10.1007/s10840-016-0146-1. Epub 2016 May 30.
2
Proof of concept study: Improvement of echocardiographic parameters after renal sympathetic denervation in CKD refractory hypertensive patients.
Int J Cardiol. 2016 Mar 15;207:6-12. doi: 10.1016/j.ijcard.2016.01.088. Epub 2016 Jan 11.
3
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Eur Heart J. 2013 Jul;34(28):2159-219. doi: 10.1093/eurheartj/eht151. Epub 2013 Jun 14.
4
Sympathetic nervous system: role in hypertension and in chronic kidney disease.
Curr Opin Nephrol Hypertens. 2012 Jan;21(1):46-51. doi: 10.1097/MNH.0b013e32834db45d.
5
Sympathetic neural activity in hypertension and related diseases.
Am J Hypertens. 2010 Oct;23(10):1052-60. doi: 10.1038/ajh.2010.154. Epub 2010 Jul 22.
6
Neurogenic hypertension.
Exp Physiol. 2010 May;95(5):569-71. doi: 10.1113/expphysiol.2009.047282.
7
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.
Circulation. 2010 Feb 23;121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667. Epub 2009 Dec 17.
8
Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.
Hypertension. 2009 Oct;54(4):690-7. doi: 10.1161/HYPERTENSIONAHA.108.119883. Epub 2009 Aug 31.
9
A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
10
Sympathetic activation in chronic renal failure.
J Am Soc Nephrol. 2009 May;20(5):933-9. doi: 10.1681/ASN.2008040402. Epub 2008 Sep 17.
Zotero 插件